Premium Nahrungsergänzungsmittel | artgerecht

Lipid Metabolism Diagnostics: Cholesterol & Lipid Panel

Lipid metabolism diagnostics involves blood tests to measure cholesterol and triglyceride levels. It helps detect cardiovascular risk factors and lipid disorders at an early stage.

Regular tips about health Regular tips about health

Things worth knowing about "Lipid metabolism diagnostics"

Lipid metabolism diagnostics involves blood tests to measure cholesterol and triglyceride levels. It helps detect cardiovascular risk factors and lipid disorders at an early stage.

What is Lipid Metabolism Diagnostics?

Lipid metabolism diagnostics refers to the medical assessment of fat metabolism in the human body. It involves measuring and evaluating various blood lipids to detect disorders early and assess the risk of cardiovascular diseases such as atherosclerosis, heart attack, and stroke. It is a key component of both preventive medicine and the management of existing lipid disorders.

Which Parameters Are Measured?

Lipid metabolism diagnostics typically involves a lipid profile (also called a lipid panel), which includes the following values:

Total cholesterol: The overall amount of cholesterol in the blood. Elevated levels may indicate an increased risk of cardiovascular disease.
LDL cholesterol (Low-Density Lipoprotein): Often called the “bad” cholesterol, it can build up in artery walls and contribute to plaque formation.
HDL cholesterol (High-Density Lipoprotein): Known as the “good” cholesterol, it helps remove excess cholesterol from the bloodstream and has a protective effect.
Triglycerides: Blood fats that serve as an energy source. Persistently elevated levels are a risk factor for cardiovascular disease.
Non-HDL cholesterol: The sum of all atherogenic lipoproteins, calculated as total cholesterol minus HDL cholesterol.

Extended Diagnostics

In certain high-risk groups or in cases of unclear findings, additional markers may be measured:

Lipoprotein(a): A genetically determined risk factor for vascular disease.
Apolipoprotein A1 and B: Carrier proteins for lipids that allow for more precise cardiovascular risk assessment.
Oxidized LDL: A marker of oxidative stress and early-stage atherosclerosis.

When Is Lipid Metabolism Diagnostics Recommended?

A lipid assessment is recommended or indicated in the following situations:

Routine preventive health check-ups (e.g., from age 35 onwards)
Known cardiovascular disease or a family history of lipid disorders
Obesity, diabetes mellitus, or high blood pressure
Monitoring during lipid-lowering therapy (e.g., with statins)
Suspected primary hypercholesterolemia or hypertriglyceridemia

How Is the Test Performed?

Lipid metabolism diagnostics is performed through a simple blood draw, usually in the morning after a 12-hour fasting period. Fasting is particularly important for the accurate measurement of triglycerides. The blood sample is analyzed in a laboratory, and results are typically available within a few hours to days.

Reference Values and Interpretation

The following reference values apply to adults according to the guidelines of the European Society of Cardiology (ESC):

Total cholesterol: < 200 mg/dL (desirable)
LDL cholesterol: < 115 mg/dL (for low-risk individuals); < 55 mg/dL for very high-risk patients
HDL cholesterol: > 40 mg/dL (men), > 45 mg/dL (women)
Triglycerides: < 150 mg/dL

The interpretation of results is always carried out in the context of the individual patient's overall cardiovascular risk profile.

Treatment Options for Abnormal Results

If lipid metabolism diagnostics reveals elevated or pathological values, several treatment approaches are available:

Lifestyle modifications: Dietary changes (low-fat, high-fiber diet), regular physical activity, and weight reduction
Medication: Statins (e.g., atorvastatin, simvastatin), fibrates, ezetimibe, or PCSK9 inhibitors, depending on the type and severity of the disorder
Treatment of underlying conditions: In secondary lipid disorders (e.g., caused by diabetes or hypothyroidism), treating the underlying disease is the primary goal

References

Mach F et al. - 2019 ESC/EAS Guidelines for the management of dyslipidaemias. European Heart Journal, 2020.
World Health Organization (WHO) - Cardiovascular diseases: Prevention and risk reduction. www.who.int, 2023.
Grundy SM et al. - 2018 AHA/ACC Guideline on the Management of Blood Cholesterol. Journal of the American College of Cardiology, 2019.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.